Lunit

Lunit Equity

The The Equity of Lunit (328130.KQ) as of Oct 18, 2026 is 6.47 B KRW. In the previous year, The Equity was 6.02 B KRW — a change of 7.41% (higher).

Equity

6.47 BKRW

YoY

7.41%

Last updated:

In 2024, Lunit's equity was 6.47 B KRW, a 7.41% increase from the 6.02 B KRW equity in the previous year.

The Lunit Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-58.87 B KRW
Jan 1, 2020
-130.64 B KRW
Jan 1, 2021
2.04 B KRW
Jan 1, 2022
6.64 B KRW
Jan 1, 2023
6.02 B KRW
Jan 1, 2024
6.47 B KRW
The Lunit Equity history
YEAREquityYoY
6.47 BKRW+7.41%
6.02 BKRW-9.30%
6.64 BKRW+225.81%
2.04 BKRW-101.56%
-130.64 BKRW+121.89%
-58.87 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Lunit's Equity

Lunit's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lunit's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Lunit's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Lunit's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Lunit’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Lunit stock

The Equity of Lunit is 6.47 B KRW in 2024.

The Equity of Lunit changed from 6.02 B KRW to 6.47 B KRW, representing a 7.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Lunit since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Lunit historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lunit

All Key Metrics — Lunit